Major capsid protein L1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 17: Line 17:
Different HPV types are tissue specific, causing different disease presentations. That is why Gardasil targets nine different types of HPV: Types 6, 11, 16, 18, 31, 33, 45, 52, and 58 <ref name="types"/>. In particular, types 16 and 18 can trigger the development and late onset of cervical carcinoma, a cancer typically seen in sexually active females that is asymptomatic for several months and upwards to a decade before ultimately leading to infertility. HPV-6 and HPV-11 can also cause cervical carcinoma but are more renowned for causing condyloma acuminatum along with oral and laryngeal papillomas. HPV-31, HPV-33, HPV-45, HPV-52, and HPV-58 are all less common causative agents of cervical intraepithelial neoplasia and cancer <ref name="Murray"/>.
Different HPV types are tissue specific, causing different disease presentations. That is why Gardasil targets nine different types of HPV: Types 6, 11, 16, 18, 31, 33, 45, 52, and 58 <ref name="types"/>. In particular, types 16 and 18 can trigger the development and late onset of cervical carcinoma, a cancer typically seen in sexually active females that is asymptomatic for several months and upwards to a decade before ultimately leading to infertility. HPV-6 and HPV-11 can also cause cervical carcinoma but are more renowned for causing condyloma acuminatum along with oral and laryngeal papillomas. HPV-31, HPV-33, HPV-45, HPV-52, and HPV-58 are all less common causative agents of cervical intraepithelial neoplasia and cancer <ref name="Murray"/>.
- 
-
.
 
</StructureSection>
</StructureSection>
== References ==
== References ==
<references/>
<references/>

Revision as of 19:19, 16 November 2016

PDB ID 2R5H

Drag the structure with the mouse to rotate

References

  1. 1.0 1.1 Zhai L, Tumban E. Gardasil-9: A global survey of projected efficacy. Antiviral Res. 2016 Jun;130:101-9. doi: 10.1016/j.antiviral.2016.03.016. Epub, 2016 Apr 1. PMID:27040313 doi:http://dx.doi.org/10.1016/j.antiviral.2016.03.016
  2. https://www.gardasil9.com
  3. 3.0 3.1 http://www.hpvvaccine.org.au/the-hpv-vaccine/how-does-it-work.aspx
  4. 4.0 4.1 https://www.medicines.org.uk/emc/medicine/19016
  5. Harper DM, Vierthaler SL, Santee JA. Review of Gardasil. J Vaccines Vaccin. 2010 Nov 23;1(107). pii: 1000107. PMID:23805398 doi:http://dx.doi.org/10.4172/2157-7560.1000107
  6. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000703/WC500021140.pdf
  7. doi: https://dx.doi.org/10.1128/JVI.77.8.4818-4826.2003
  8. http://dx.doi.org/10.1016/j.virol.2013.05.038
  9. http://www.uniprot.org/uniprot/P03101
  10. https://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_ppi.pdf
  11. doi: https://dx.doi.org/10.4161/hv.3.4.4309
  12. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm096052.htm
  13. 13.0 13.1 13.2 Murray, Patrick R., Ken S. Rosenthal, and Michael A. Pfaller. "Papillomavirus and Polyomavirus." Medical Microbiology. Philadelphia: Elsevier/Saunders, 2013. 445-450.
Personal tools